These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 208747

  • 1. Cell-mediated immunity to varicella zoster virus in children being treated for cancer.
    Hayes FA, Feldman S.
    Cancer; 1978 Jul; 42(1):159-63. PubMed ID: 208747
    [Abstract] [Full Text] [Related]

  • 2. Delayed hypersensitivity skin test to detect susceptibility to varicella and zoster.
    Berger R, Luescher D, Just M, D'Hondt E, Bogaert H.
    Postgrad Med J; 1985 Jul; 61 Suppl 4():137-41. PubMed ID: 3014471
    [Abstract] [Full Text] [Related]

  • 3. VZV T cell-mediated immunity.
    Weinberg A, Levin MJ.
    Curr Top Microbiol Immunol; 2010 Jul; 342():341-57. PubMed ID: 20473790
    [Abstract] [Full Text] [Related]

  • 4. Cell-mediated immunity to varicella-zoster virus infection in strain 2 guinea pigs.
    Jenski L, Myers MG.
    J Med Virol; 1987 Sep; 23(1):23-30. PubMed ID: 2824676
    [Abstract] [Full Text] [Related]

  • 5. Antibody to early antigens of varicella-zoster virus during varicella and zoster.
    Gerna G, Cereda PM, Cattaneo E, Achilli G, Gerna MT.
    J Infect Dis; 1979 Jul; 140(1):33-41. PubMed ID: 88490
    [Abstract] [Full Text] [Related]

  • 6. Proliferative response to varicella-zoster virus is inverse related to development of high levels of varicella-zoster virus specific IgG antibodies.
    Terada K, Kawano S, Yoshihiro K, Morita T.
    Scand J Infect Dis; 1993 Jul; 25(6):775-8. PubMed ID: 8052820
    [Abstract] [Full Text] [Related]

  • 7. Subclinical varicella-zoster virus viremia, herpes zoster, and T lymphocyte immunity to varicella-zoster viral antigens after bone marrow transplantation.
    Wilson A, Sharp M, Koropchak CM, Ting SF, Arvin AM.
    J Infect Dis; 1992 Jan; 165(1):119-26. PubMed ID: 1309369
    [Abstract] [Full Text] [Related]

  • 8. Detection of varicella-zoster virus-specific IgA antibodies in varicella and zoster patients and in healthy adults of various ages by solid-phase radioimmunoassay.
    Levy E, Mosovitz B, Friedman M, Sarov I.
    Intervirology; 1983 Jan; 20(2-3):123-8. PubMed ID: 6313543
    [Abstract] [Full Text] [Related]

  • 9. Herpes zoster and impaired cell-associated immunity to the varicella-zoster virus in patients with Hodgkin's disease.
    Ruckdeschel JC, Schimpff SC, Smyth AC, Mardiney MR.
    Am J Med; 1977 Jan; 62(1):77-85. PubMed ID: 189604
    [Abstract] [Full Text] [Related]

  • 10. Ability of yeast Ty-VLPs (virus-like particles) containing varicella-zoster virus (VZV)gE and assembly protein fragments to induce in vitro proliferation of human lymphocytes from VZV immune patients.
    Welsh MD, Harper DR, Garcia-Valcarcel M, Fowler WJ, Aitken C, Jeffries DJ, Layton GT.
    J Med Virol; 1999 Sep; 59(1):78-83. PubMed ID: 10440812
    [Abstract] [Full Text] [Related]

  • 11. Varicella-Zoster virus-specific cell-mediated immunity in HIV-infected children receiving highly active antiretroviral therapy.
    Weinberg A, Wiznia AA, LaFleur BJ, Shah S, Levin MJ.
    J Infect Dis; 2004 Jul 15; 190(2):267-70. PubMed ID: 15216460
    [Abstract] [Full Text] [Related]

  • 12. Cell-mediated immunity to varicella-zoster virus.
    Arvin AM.
    J Infect Dis; 1992 Aug 15; 166 Suppl 1():S35-41. PubMed ID: 1320649
    [Abstract] [Full Text] [Related]

  • 13. Development and characteristics of the cellular immune response to infection with varicella-zoster virus.
    Kumagai T, Chiba Y, Wataya Y, Hanazono H, Chiba S, Nakao T.
    J Infect Dis; 1980 Jan 15; 141(1):7-13. PubMed ID: 6245148
    [Abstract] [Full Text] [Related]

  • 14. Immune response and tolerability of varicella vaccine in children and adolescents with systemic lupus erythematosus previously exposed to varicella-zoster virus.
    Barbosa CM, Terreri MT, Rosário PO, de Moraes-Pinto MI, Silva CA, Hilário MO.
    Clin Exp Rheumatol; 2012 Jan 15; 30(5):791-8. PubMed ID: 22935227
    [Abstract] [Full Text] [Related]

  • 15. Reduction in the Number of Varicella-Zoster Virus-Specific T-Cells in Immunocompromised Children with Varicella.
    Murata K, Hoshina T, Onoyama S, Tanaka T, Kanno S, Ishimura M, Koga Y, Nakayama H, Ohga S.
    Tohoku J Exp Med; 2020 Mar 15; 250(3):181-190. PubMed ID: 32213753
    [Abstract] [Full Text] [Related]

  • 16. Congenital varicella-zoster virus infection and the failure to establish virus-specific cell-mediated immunity.
    Grose C.
    Mol Biol Med; 1989 Oct 15; 6(5):453-62. PubMed ID: 2560525
    [Abstract] [Full Text] [Related]

  • 17. Varicella-zoster virus infection in children with underlying human immunodeficiency virus infection.
    Gershon AA, Mervish N, LaRussa P, Steinberg S, Lo SH, Hodes D, Fikrig S, Bonagura V, Bakshi S.
    J Infect Dis; 1997 Dec 15; 176(6):1496-500. PubMed ID: 9395360
    [Abstract] [Full Text] [Related]

  • 18. Clinical course and therapeutic approach to varicella zoster virus infection in children with rheumatic autoimmune diseases under immunosuppression.
    Leuvenink R, Aeschlimann F, Baer W, Berthet G, Cannizzaro E, Hofer M, Kaiser D, Schroeder S, Heininger U, Woerner A.
    Pediatr Rheumatol Online J; 2016 Jun 02; 14(1):34. PubMed ID: 27256096
    [Abstract] [Full Text] [Related]

  • 19. Varicella Zoster Virus: A Common Cause of Stroke in Children and Adults.
    Amlie-Lefond C, Gilden D.
    J Stroke Cerebrovasc Dis; 2016 Jul 02; 25(7):1561-1569. PubMed ID: 27138380
    [Abstract] [Full Text] [Related]

  • 20. Antibody responses to early antigens of varicella-zoster virus (VZV) during varicella and zoster.
    Namazue J, Kato T, Yamanishi K, Takahashi M, Asano Y, Muraki R.
    Biken J; 1986 Dec 02; 29(3-4):91-7. PubMed ID: 3039973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.